Not everyone, however, has enough B12 in their bodies from diet alone, and this can lead to issues such as anemia
Blue Cross Blue Shield of Michigan, the state's largest health insurer, announced it would end its funding for GLP-1 obesity drugs starting from January 1 next year
Mol Metab 3(2):191201 Wilson-Perez HE et al (2013) Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency
If your diabetes isn't being controlled with other medications, your doctor might consider Ozempic as a treatment option that the NHS can cover
Its always better to err on the side of caution and get checked out
GLP-1 agonists primarily reduce appetite and slow digestion, leading to reduced calorie intake